article thumbnail

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

Pharmaceutical Technology

The platform could potentially forecast and design several tumour vaccines that can trigger certain immune responses to fight tumours. Additionally, the platform could produce preclinical tumour vaccine candidate compounds with strong immune activity by incorporating algorithmic feedback to streamline activity and efficacy.

article thumbnail

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

TNF-alpha is an immune modulating cytokine whose dysregulation can lead to prolonged inflammatory responses and is known to drive disease in a range of autoimmune and inflammatory disorders. MYMD-1 has shown effectiveness in pre-clinical and clinical studies in regulating the immune system.

article thumbnail

The next industrial revolution in India will be driven by biotechnology

Express Pharma

He praised the reforms undertaken by the Government in the last decade, which have helped the industry thrive, particularly through structural and process improvements. He urged the Government to continue the support through initiatives like the PLI scheme, which directly impacts industry growth.

Vaccines 105